Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels von RUSTIN, Gordon J. S, MARPLES, Maria, NELSTROP, Ann E, MAHMOUDI, Mohamed, MEYER, Tim

Volltext

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125 von RUSTIN, G. J. S, NELSTROP, A. E, MCCLEAN, P, BRADY, M. F, MCGUIRE, W. P, HOSKINS, W. J, MITCHELL, H, LAMBERT, H. E

Volltext

Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study von Rustin, G. J. S., Nelstrop, A. E., Tuxen, M. K., Lambert, H. E.

Volltext

Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer von Meyer, T., Nelstrop, A. E., Mahmoudi, M., Rustin, G. J.S.

Volltext

Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials von RUSTIN, G. J. S, NELSTROP, A. E, BENTZEN, S. M, BOND, S. J, MCCLEAN, P

Volltext

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma: A North Thames ovary group study von LAMBERT, H. E, RUSTIN, G. J. S, GREGORY, W. M, NELSTROP, A. E

Volltext

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer von Guppy, A E, Nelstrop, A E, Foster, T, Agarwal, R, Seckl, M J, Rustin, G J S

Volltext

Comparison of Standard and CA-125 Response Criteria in Patients With Epithelial Ovarian Cancer Treated With Platinum or Paclitaxel von BRIDGEWATER, J. A, NELSTROP, A. E, RUSTIN, G. J. S, GORE, M. E, MCGUIRE, W. P, HOSKINS, W. J

Volltext

Use of tumour markers in monitoring the course of ovarian cancer von RUSTIN, G. J. S, NELSTROP, A. E, BENTZEN, S. M, PICCART, M. J, BERTELSEN, K

Volltext

Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 von RUSTIN, G. J. S, NELSTROP, A. E, CRAWFORD, M, LEDERMANN, J, LAMBERT, H. E, COLEMAN, R, JOHNSON, J, EVANS, H, BROWN, S, OSTER, W

Volltext

Long‐term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age‐matched normal population... von Lambert, H. E., Gregory, W. M., Nelstrop, A. E., Rustin, G. J. S.

Volltext

A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study von LAMBERT, H. E, RUSTIN, G. J. S, GREGORY, W. M, NELSTROP, A. E

Volltext

Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy von Lee, C.K, Pires de Miranda, M, Ledermann, J.A, Ruiz de Elvira, M.-C, Nelstrop, A.E, Lambert, H.E, Rustin, G.J.S, Trask, C.W.L

Volltext

Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer von Tuxen, M. K., Rustin, G. J. S., Dombernowsky, P., Sölétormos, G., Nelstrop, A. E.

Volltext

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer von RUSTIN, G. J. S, QUINNELL, T. G, JOHNSON, J, CLARKE, H, NELSTROP, A. E, BOLLAG, W

Volltext

Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population von Lambert, H. E., Gregory, W. M., Nelstrop, A. E., Rustin, G. J. S.

Volltext

Studies on phagocytosis. 3. Antigen clearance studies in invertebrates and poikilothermic vertebrates von Nelstrop, A E, Taylor, G, Collard, P

Volltext

Studies on phagocytosis. I. Antigen clearance studies in rabbits von Nelstrop, A E, Taylor, G, Collard, P

Volltext

Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group von Rustin, G J, Gennings, J N, Nelstrop, A E, Covarrubias, H, Lambert, H E, Bagshawe, K D

Volltext

Studies on phagocytosis. II. In vitro phagocytosis by macrophages von Nelstrop, A E, Taylor, G, Collard, P

Volltext